HPGDS inhibitor 3 - CAS 2255311-93-2

HPGDS inhibitor 3 is a powerful oral compound that selectively inhibits the hematopoietic prostaglandin D synthase (H-PGDS) . With an IC50 value of 9.4 nM and EC50 of 42 nM, it demonstrates high potency in peripherally restricting H-PGDS. Moreover, HPGDS inhibitor 3 exhibits excellent selectivity with no associated central nervous system toxicity. This compound also possesses favorable pharmacokinetic properties in mouse, rat, and dog models. Additionally, HPGDS inhibitor 3 displays noteworthy anti-inflammatory activity [1].

Others, PGE Synthase

Immunology/Inflammation, Others

2255216

C21H27N3O2

353.46

C(N[C@@H]1CC[C@@H](C(C)(C)O)CC1)(=O)C2=CC3=C(N=C(C=C3)C4CC4)N=C2

-20°C

Ice Packs

Small Compound